Mustang Bio
MBIO
71 hedge funds and large institutions have $10.3M invested in Mustang Bio in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 23 closing their positions.
0.01% less ownership
Funds ownership: 0.03% → 0.02% (-0.01%)
12% less funds holding
Funds holding: 81 → 71 (-10)
39% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 23
40% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 25
59% less capital invested
Capital invested by funds: $25.2M → $10.3M (-$14.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
+$1.07M |
| 2 |
Millennium Management
New York
|
+$463K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$380K |
| 4 |
E
Ergoteles
New York
|
+$249K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$113K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.52M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.32M |
| 3 |
State Street
Boston,
Massachusetts
|
-$896K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$589K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$471K |
MBIO Hedge Fund Activity: Q2 2022 in Review
71 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2022, worth a combined $10.3M — down 59% from $25.2M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of MBIO and 14 opened new positions — a net loss of 9 holders — while 25 trimmed existing stakes and 15 added.
The largest buyer was Laurion Capital Management, opening a new position worth an estimated $1.07M. The largest seller was BlackRock, cutting an estimated $2.52M.
- 71 institutional investors held Mustang Bio (MBIO) as of Q2 2022, down from 81 in Q1 2022.
- Funds reported $10.3M of Mustang Bio stock for Q2 2022, down 59% quarter-over-quarter.
- 14 funds opened new Mustang Bio positions in Q2 2022 and 23 closed out, a net change of -9 holders.
- The largest Mustang Bio buyer in Q2 2022 was Laurion Capital Management, an estimated $1.07M added.
- The largest Mustang Bio seller in Q2 2022 was BlackRock, an estimated $2.52M sold.
Based on aggregated 13F filings for Q2 2022.